New York, NY -- (SBWIRE) -- 01/28/2014 -- King Penny Stocks is an elite financial community for investors and traders alike who are looking to potentially gain financial freedom through the markets on undervalued companies and “in-play” momentum penny stocks. Today we bring special trend analysis of following stocks: BioDelivery Sciences International, Inc. (NASDAQ:BDSI), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Galena Biopharma Inc (NASDAQ:GALE), Synta Pharmaceuticals Corp. (NASDAQ:SNTA).
PLUS you’ll get KingPennyStock’s Pro Trading Rules Mini E-book absolutely FREE! Claim Your Copy
BioDelivery Sciences International, Inc. (NASDAQ:BDSI) stock moved down -13.60% and finished the day at $8.13, while its opening price was $9.11.The company traded with the total volume of 2.36 million shares, while its average trading volume remained 940,551.00 shares. During the last one month it rose with the percentage of 35.95. BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapeutics in the areas of pain management and oncology supportive care.
Has BDSI Found The Bottom and Ready To Move Up? Find out Here
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) percentage change reduced -12.01% to close at $7.91 with the total traded volume of 81.31 million shares, and average volume of 34.59 million. The Company’s year to date performance remained optimistic with the rise of 15.98%. During last trade its minimum price was $7.57 and it gained its highest price of $9.74. ARIAD Pharmaceuticals, Inc., an oncology company, focuses on the discovery, development, and commercialization of medicines for cancer patients.
Has ARIA Found The Bottom And Ready To Gain Momentum? Find Out Here
Galena Biopharma Inc (NASDAQ:GALE) started its trading session with the price of $5.80 and closed at $5.06 by scoring -11.23%. The stocks traded with total volume of 14.08 million shares, while the average trading volume remained 8.51 million shares. Previous 5 days graph demonstrated a negative move of -27.71%. The 52-week price range of the stock remained $1.65 - $7.77. Galena Biopharma, Inc., a biopharmaceutical company, focuses on developing oncology treatments to address major unmet medical needs to advance cancer care.
Why Should Investors Buy GALE After the Recent Fall? Just Go Here and Find Out
Synta Pharmaceuticals Corp. (NASDAQ:SNTA) during the previous trading session, the stock showed a negative movement of -10.51%. SNTA traded with volume of 3.12 million shares, while its average trading volume remained 1.96 million shares. Stock’s closing price was $5.45 while it started its day-trade at $6.05. Its 52-week price range was $3.70 - $11.88. Synta Pharmaceuticals Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs for treating severe medical conditions, including cancer and chronic inflammatory diseases.
Will SNTA Get Buyers Even After The Recent Rally? Find Out Here
About King Penny Stocks
King Penny Stocks provides up to the minute dissemination of news while reporting on stocks that are actively traded in the small cap arena whether trading on the Nasdaq small caps, AMEX or the OTC markets. Since performance is key in our industry, it’s no wonder why our ground breaking alerts on active stocks have brought us to the forefront of this industry. Our due diligence on trend analysis has caught the attention of the very best chart technicians in the business.
King Penny Stocks is an elite financial community for investors and traders alike who are looking to potentially gain financial freedom through the markets on undervalued companies and “in-play” momentum penny stocks. Get detailed breakdowns of major trends impacting the markets?
Our newsletter, Press Release and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company.
An individual should never invest in the securities of any of the company’s profiled based solely on information contained in our report. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research. This report/release/advertisement is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation.
Read our Full Disclaimer at: http://kingpennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)